Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Gastroenterology Reports

12-03-2024 | Irritable Bowel Syndrome

Integrative Approaches to Managing Gut Health

Author: Marvin M. Singh

Published in: Current Gastroenterology Reports

Login to get access

Abstract

Purpose of Review

To summarize key integrative approaches to managing common gastrointestinal conditions.

Recent Findings

Lifestyle interventions like diet, exercise, and stress reduction impact the gut microbiome and gastrointestinal symptoms. Evidence supports mind-body therapies, herbs, certain supplements, and other modalities as complimentary approaches, when appropriate, for common conditions like irritable bowel syndrome or gastroesophageal reflux disease.

Summary

An integrative approach optimizes both conventional treatments and incorporates lifestyle modifications, complimentary modalities, and the doctor-patient relationship.
Footnotes
1
Heidelbaugh J et al. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome with Constipation. Gastroenterology 2022;163:118–136.
 
Literature
1.
2.
McEwen BS. Integrative medicine: breaking down silos of knowledge and practice an epigenetic approach. Metabolism. 2017;69S:S21–9.CrossRefPubMed
3.
Chow E, et al. A body-mind-Spirit Model in Health. Soc Work Health Care. 2008;34(3–4):261–82.
4.
Skirbekk H, Middelthon AL, Hjortdahl P, Finset A. Mandates of trust in the doctor-patient relationship. Qual Health Res. 2011;21(9):1182–90.CrossRefPubMed
5.
Hills RD Jr., Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019;11(7).
6.
7.
* Singh M. Lifestyle Medicine. In: Mullin G, Singh M, Parian A, Clarke J, ed. Integrative Gastroenterology. 2 ed: Oxford University Press; 2020:599–616. An important review of how lifestyle medicine impacts the gut microbiome and overall health and it’s role in managing gastrointestinal disease.
8.
Baratta F, Pastori D, Polimeni L, et al. Adherence to Mediterranean Diet and non-alcoholic fatty liver disease: effect on insulin resistance. Am J Gastroenterol. 2017;112(12):1832–9. Important article reviewing the role of the Mediterranean diet in NAFLD, fatty liver disease, and insulin resistance. It underscores the importance of a healthy well-balance diet in the management of gut health.CrossRefPubMed
9.
Kolodziejczyk A, Zheng D, Elinav E. Diet-Microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;7:742–53.CrossRef
10.
Rosenfeld CS. Gut dysbiosis in animals due to Environmental Chemical exposures. Front Cell Infect Microbiol. 2017;7:396. An important article that reviews how environmental chemicals can influence the gut microbiome which can lead to impacts on overall health.
11.
Singh M, Mullin G, Diet. Environmental Chemicals, and the Gut Microbiome. In: Cohen A, vom Saal F, ed. Integrative Environmental Medicine. Vol 1. 1 ed2017.
12.
Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary Emulsifier-Induced Low-Grade inflammation promotes Colon carcinogenesis. Cancer Res. 2017;77(1):27–40.CrossRefPubMed
13.
14.
Alammar N, Mullin G. The irritable bowel syndrome. In: Mullin GSM, Parian A, Clarke J, editors. Integrative gastroenterology. Volume 2. ed: Oxford University Press; 2020. pp. 435–57.
15.
Choi JJ, Eum SY, Rampersaud E, Daunert S, Abreu MT, Toborek M. Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ Health Perspect. 2013;121(6):725–30.CrossRefPubMedPubMedCentral
16.
Poroyko VA, Carreras A, Khalyfa A, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep. 2016;6:35405.ADSCrossRefPubMedPubMedCentral
17.
Erdman SE, Poutahidis T. Microbes and oxytocin: benefits for host physiology and behavior. Int Rev Neurobiol. 2016;131:91–126.CrossRefPubMed
18.
Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. Mindfulness mediates the physiological markers of stress: systematic review and meta-analysis. J Psychiatr Res. 2017;95:156–78.CrossRefPubMed
19.
Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.CrossRefPubMed
20.
Schoenfeld P. Advances in IBS 2016: a review of current and Emerging Data. Gastroenterol Hepatol. 2016;12(8 Suppl 3):1–11.
21.
Ford AC, Quigley EM, Lacy BE, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350–65.CrossRefPubMed
22.
* D’Silva A, MacQueen G, Nasser Y, Taylor LM, Vallance JK, Raman M. Yoga as a Therapy for Irritable Bowel Syndrome. Dig Dis Sci. 2019. An important article which reviews the role of yoga (an integrative therapy) in the role of IBS. This underscores the importance and utility of non-medicinal therapies in the management of gut health.
23.
Taneja I, Deepak KK, Poojary G, Acharya IN, Pandey RM, Sharma MP. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback. 2004;29(1).
24.
Zhao J, Lu J, Yin X, et al. Comparison of electroacupuncture and mild-warm moxibustion on brain-gut function in patients with constipation-predominant irritable bowel syndrome: a randomized controlled trial. Chin J Integr Med. 2018;24(5):328–35.CrossRefPubMed
25.
Amato A, Liotta R, Mule F. Effects of menthol on circular smooth muscle of human colon: analysis of the mechanism of action. Eur J Pharmacol. 2014;740:295–301.CrossRefPubMed
26.
Patrick L. Gastroesophageal reflux disease (GERD): a review of conventional and alternative treatments. Altern Med Rev. 2011;16(2):116–33.PubMed
27.
Sethi T. Constipation. In: Mullin G, Singh M, Parian A, Clarke J, editors. Integrative gastroenterology. Volume 2. ed: Oxford University Press; 2020. pp. 411–34.
28.
Ciampa B, Ramos E, Borum M, Doman D. The emerging therapeutic role of Medical Foods for Gastrointestinal disorders. Gastroenterol Hepatol. 2017;13(2):104–15.
29.
Mullin G, Swift M. The Inside Tract. Rodale; 2011.
30.
Arrouk R, Herdes RE, Karpinski AC, Hyman PE. Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome. Pediatr Health Med Ther. 2018;9:129–33.CrossRef
31.
Valentin N, Camilleri M, Carlson P et al. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep. 2017;5(5).
32.
Doldo P, Cosco V, Garieri P, Ruggiero G, Mancina RM, Cosco C, Spagnuolo R. Beta-glucan, inositol, and digestive enzymes improve quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017;21(2 Supp):102–7.PubMed
33.
Verne GN, Salameh H, Basra S, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019;68(6):996–1002.CrossRefPubMed
34.
Siva S, Rubin DT, Gulotta G, Wroblewski K, Pekow J. Zinc Deficiency is Associated with Poor Clinical outcomes in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(1):152–7.CrossRefPubMed
35.
Lang A, Salomon N, Wu JC, et al. Curcumin in Combination with Mesalamine induces remission in patients with mild-to-moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2015;13(8):1444–e14491441.CrossRefPubMed
36.
Langhorst J, Wulfert H, Lauche R, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015;9(1):86–106.CrossRefPubMed
37.
Hood MM, Jedel S. Mindfulness-based interventions in inflammatory bowel disease. Gastroenterol Clin North Am. 2017;46(4):859–74.CrossRefPubMed
38.
Abraham BP, Quigley EMM. Probiotics in Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017;46(4):769–82.CrossRefPubMed
39.
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–62.CrossRefPubMed
40.
Slater R, Mathis SS, Sierpina V. Upper Gastrointestinal disorders: GERD, Dyspepsia, and peptic Ulcer Disease. In: Mullin G, Singh M, Parian A, Clarke J, editors. Integrative gastroenterology. Volume 2. ed: Oxford University Press; 2020. pp. 363–90.
41.
42.
Ghayur MN, Gilani AH. Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci. 2005;50(10):1889–97.CrossRefPubMed
43.
Wu K, Rayner C, Chuah S, et al. Effects of ginger on gastric emptying and motility in healthy humans. Eur J Gastroenterol Hepatol. 2008;20(5):436–40.CrossRefPubMed
44.
Bang CS, Yang YJ, Baik GH. Melatonin for the treatment of gastroesophageal reflux disease; protocol for a systematic review and meta-analysis. Med (Baltim). 2019;98(4):e14241.CrossRef
45.
Glasinovic E, Wynter E, Arguero J, et al. Treatment of supragastric belching with cognitive behavioral therapy improves qualit of life and reduces acid gastroesophageal reflux. Am J Gastroenterol. 2018;113(4):539–47.CrossRefPubMed
46.
Malfertheiner P. STW 5 (Iberogast) Therapy in Gastrointestinal Functional disorders. Dig Dis. 2017;35(Suppl 1):25–9.CrossRefPubMed
47.
48.
Chedid V, Clarke J, Roland B, Dunbar K, Koh J, Justino E, Tomakin E, Mullin G. Herbal therapy is equivalent to Rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014;3(3):16–24.CrossRefPubMedPubMedCentral
49.
Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect. 1999;1(2):125–9.CrossRefPubMed
50.
Wah Kheong C, Nik Mustapha NR, Mahadeva S. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940–9. e1948.CrossRefPubMed
51.
Antunes C, Dadabhai A. Liver Disease. In: Mullin G, Singh M, Parian A, Clarke J, editors. Integrative gastroenterology. 2 ed. Oxford University Press; 2020.
Metadata
Title
Integrative Approaches to Managing Gut Health
Author
Marvin M. Singh
Publication date
12-03-2024
Publisher
Springer US
Published in
Current Gastroenterology Reports
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-024-00927-7
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits